Cargando…
Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis
Viral hepatitis remains a significant worldwide threat, in spite of the availability of several successful therapeutic and vaccination strategies. Complications associated with acute and chronic infections, such as liver failure, cirrhosis and hepatocellular carcinoma, are the cause of considerable...
Autores principales: | Dey, Debajit, Banerjee, Manidipa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075008/ https://www.ncbi.nlm.nih.gov/pubmed/27777893 http://dx.doi.org/10.14218/JCTH.2016.00025 |
Ejemplares similares
-
In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor
por: Dey, Debajit, et al.
Publicado: (2020) -
The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity
por: Shukla, Ashutosh, et al.
Publicado: (2015) -
A smart viral vector for targeted delivery of hydrophobic drugs
por: Ghosh, Sukanya, et al.
Publicado: (2021) -
The effect of amantadine on an ion channel protein from Chikungunya virus
por: Dey, Debajit, et al.
Publicado: (2019) -
Role of Disulphide Bonds in Membrane Partitioning of a Viral Peptide
por: Sikdar, Samapan, et al.
Publicado: (2022)